ALPINE IMMUNE SCIENCES, INC. - 02083G100

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2024 · Q4 2023
Value (USD)
Total reported value ($000)
$1.375B
QoQ value delta ($000)
+$799.4M (+138.8%)
Implied price effect (QoQ)
+107.04%
Shares
Total shares
34,857,010
QoQ shares delta
+4,636,572 (+15.34%)
Total shares held by funds (by quarter)

Top holders (Q1 2024)

Top 25 only Full list
Partial Q1 2024 data: 107 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Avoro Capital Advisors LLC 228,921 5,775,000 2.67%
Frazier Life Sciences Management, L.P. 124,113 3,131,008 5.24%
STATE STREET CORP 112,809 2,845,839 0.01%
VANGUARD GROUP INC 107,514 2,712,285 0.0%
ORBIMED ADVISORS LLC 106,254 2,680,496 1.95%
Paradigm Biocapital Advisors LP 84,082 2,121,163 2.96%
Darwin Global Management, Ltd. 78,567 1,982,016 10.46%
FRANKLIN RESOURCES INC 43,334 1,093,203 0.01%
GEODE CAPITAL MANAGEMENT, LLC 36,101 910,599 0.0%
MORGAN STANLEY 31,301 789,645 0.0%
TWO SIGMA ADVISERS, LP 26,510 668,775 0.06%
TWO SIGMA INVESTMENTS, LP 20,611 519,971 0.05%
JANUS HENDERSON GROUP PLC 17,839 450,827 0.01%
Candriam S.C.A. 16,450 415,000 0.11%
EVENTIDE ASSET MANAGEMENT, LLC 16,194 408,542 0.25%
BALYASNY ASSET MANAGEMENT L.P. 14,785 372,995 0.03%
NORTHERN TRUST CORP 13,545 341,701 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 13,443 339,142 0.0%
Bank of New York Mellon Corp 12,920 325,943 0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. 12,288 310,000 0.02%
Invesco Ltd. 10,806 272,627 0.0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 10,593 267,232 0.04%
Woodline Partners LP 10,081 254,334 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 9,821 247,760 0.0%
RENAISSANCE TECHNOLOGIES LLC 9,711 244,981 0.02%